Thomas S. Scanlan

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Amide prodrugs of small molecule nuclear receptor modulators
- Patent number 11,613,517
- Issue date Mar 28, 2023
- Oregon Health & Science University
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of sobetirome
- Patent number 11,578,032
- Issue date Feb 14, 2023
- Oregon Health & Science University
- Thomas Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sobetirome in the treatment of myelination diseases
- Patent number 11,510,887
- Issue date Nov 29, 2022
- Oregon Health & Science University
- Thomas S. Scanlan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Amide compounds, pharmaceutical compositions thereof, and methods o...
- Patent number 11,325,886
- Issue date May 10, 2022
- Oregon Health & Science University
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of sobetirome
- Patent number 11,104,654
- Issue date Aug 31, 2021
- Oregon Health & Science University
- Thomas S. Scanlan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Derivatives of sobetirome
- Patent number 10,870,616
- Issue date Dec 22, 2020
- Oregon Health & Science University
- Thomas Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of sobetirome
- Patent number 10,544,075
- Issue date Jan 28, 2020
- Oregon Health & Science University
- Thomas Scanlan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Derivatives of sobetirome
- Patent number 10,392,356
- Issue date Aug 27, 2019
- Oregon Health & Science University
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sobetirome in the treatment of myelination diseases
- Patent number 10,226,438
- Issue date Mar 12, 2019
- Oregon Health & Science University
- Thomas S. Scanlan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Derivatives of sobetirome
- Patent number 9,701,650
- Issue date Jul 11, 2017
- Oregon Health & Science University
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Development of new selective estrogen receptor modulators
- Patent number 8,263,661
- Issue date Sep 11, 2012
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective estrogen receptor modulator compositions and methods for...
- Patent number 8,236,987
- Issue date Aug 7, 2012
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-steroidal ligands for the glucocorticoid receptor, and composit...
- Patent number 7,947,726
- Issue date May 24, 2011
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-steroidal antiandrogens
- Patent number 7,645,885
- Issue date Jan 12, 2010
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-steroidal ligands for the glucocorticoid receptor, compositions...
- Patent number 7,485,660
- Issue date Feb 3, 2009
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thyronamine derivatives and analogs and methods of use thereof
- Patent number 7,355,079
- Issue date Apr 8, 2008
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thyronamine derivatives and analogs and methods of use thereof
- Patent number 7,339,079
- Issue date Mar 4, 2008
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thyronamine derivatives and analogs and methods of use thereof
- Patent number 7,321,065
- Issue date Jan 22, 2008
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for creating specific, high affinity nuclear receptor pharma...
- Patent number 7,302,347
- Issue date Nov 27, 2007
- The Regents of the University of California
- John D. Baxter
- G01 - MEASURING TESTING
Information Patent Grant
Development of new selective estrogen receptor modulators
- Patent number 7,196,119
- Issue date Mar 27, 2007
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Eye treatments using synthetic thyroid hormone compositions
- Patent number 7,122,579
- Issue date Oct 17, 2006
- The Regents of the University of California
- Daniel M. Schwartz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thyronamine derivatives and analogs and methods of use thereof
- Patent number 6,979,750
- Issue date Dec 27, 2005
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-steroidal ligands for the glucocorticoid receptor, compositions...
- Patent number 6,831,093
- Issue date Dec 14, 2004
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Eye treatments using synthetic thyroid hormone compositions
- Patent number 6,555,582
- Issue date Apr 29, 2003
- The Regents of the University of California
- Daniel M. Schwartz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nuclear receptor ligands and ligand binding domains
- Patent number 6,266,622
- Issue date Jul 24, 2001
- Regents of the University of California
- Thomas S. Scanlan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nuclear receptor ligands and ligand binding domains
- Patent number 6,236,946
- Issue date May 22, 2001
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thyroid hormone analogues and methods for their preparation
- Patent number 6,107,517
- Issue date Aug 22, 2000
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Eye treatments using synthetic thyroid hormone compositions
- Patent number 6,054,485
- Issue date Apr 25, 2000
- Regents of the University of California
- Daniel M. Schwartz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptide synthesis with sulfonyl protecting groups
- Patent number 5,942,601
- Issue date Aug 24, 1999
- The Reagents of the University of California
- Stephen C. Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective thyroid hormone analogs
- Patent number 5,883,294
- Issue date Mar 16, 1999
- The Regeants of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
USE OF SOBETIROME AND PRODRUGS AND DERIVATIVES THEREOF FOR TREATING...
- Publication number 20240307334
- Publication date Sep 19, 2024
- LIEBER INSTITUTE, INC.
- Brady Maher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS O...
- Publication number 20210284599
- Publication date Sep 16, 2021
- Oregon Health & Science University
- Thomas S. SCANLAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMIDE PRODRUGS OF SMALL MOLECULE NUCLEAR RECEPTOR MODULATORS
- Publication number 20210087137
- Publication date Mar 25, 2021
- Oregon Health & Science University
- Thomas S. SCANLAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF SOBETIROME
- Publication number 20210002208
- Publication date Jan 7, 2021
- Oregon Health & Science University
- Thomas SCANLAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOBETIROME IN THE TREATMENT OF MYELINATION DISEASES
- Publication number 20200405669
- Publication date Dec 31, 2020
- Oregon Health & Science University
- Thomas S. Scanlan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DERIVATIVES OF SOBETIROME
- Publication number 20200325092
- Publication date Oct 15, 2020
- Oregon Health & Science University
- Thomas SCANLAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DERIVATIVES OF SOBETIROME
- Publication number 20200181103
- Publication date Jun 11, 2020
- Oregon Health & Science University
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF SOBETIROME
- Publication number 20190210950
- Publication date Jul 11, 2019
- Oregon Health & Science University
- Thomas SCANLAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOBETIROME IN THE TREATMENT OF MYELINATION DISEASES
- Publication number 20190175531
- Publication date Jun 13, 2019
- Oregon Health & Science University
- Thomas S. Scanlan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DERIVATIVES OF SOBETIROME
- Publication number 20180057472
- Publication date Mar 1, 2018
- Oregon Health & Science University
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF SOBETIROME
- Publication number 20160244418
- Publication date Aug 25, 2016
- Oregon Health & Science University
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOBETIROME IN THE TREATMENT OF MYELINATION DISEASES
- Publication number 20160081955
- Publication date Mar 24, 2016
- Oregon Health & Science University
- Thomas S. Scanlan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FOOD OR BEVERAGE COMPOSITION FORTIFIED WITH THYRONAMINES AND/OR THY...
- Publication number 20140018426
- Publication date Jan 16, 2014
- T*AMINE, LLC.
- Joel R.L. Ehrenkranz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS INCLUDING 3,5-L-T2 AND METHODS OF USE THEREOF
- Publication number 20120065267
- Publication date Mar 15, 2012
- T*AMINE, LLC.
- Joel R.L. Ehrenkranz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-STEROIDAL LIGANDS FOR THE GLUCOCORTICOID RECEPTOR, COMPOSITIONS...
- Publication number 20110218225
- Publication date Sep 8, 2011
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Development of New Selective Estrogen Receptor Modulators
- Publication number 20110152226
- Publication date Jun 23, 2011
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FOOD OR BEVERAGE COMPOSITION FORTIFIED WITH THYRONAMINES AND/OR THY...
- Publication number 20110070291
- Publication date Mar 24, 2011
- T*AMINE, LLC.
- Joel R.L. Ehrenkranz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Non-Steroidal Ligands for the Glucocorticoid Receptor, Compositions...
- Publication number 20090137655
- Publication date May 28, 2009
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE ESTROGEN RECEPTOR MODULATOR COMPOSITIONS AND METHODS FOR...
- Publication number 20090124698
- Publication date May 14, 2009
- Oregon Health & Science University
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THYRONAMINE DERIVATIVES AND ANALOGS AND METHODS OF USE THEREOF
- Publication number 20090105347
- Publication date Apr 23, 2009
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Development of new selective estrogen receptor modulators
- Publication number 20080214609
- Publication date Sep 4, 2008
- The Regents of the University of California.
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Non-Steroidal Antiandrogens
- Publication number 20070049629
- Publication date Mar 1, 2007
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thyronamine derivatives and analogs and methods of use thereof
- Publication number 20060035980
- Publication date Feb 16, 2006
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thyronamine derivatives and analogs and methods of use thereof
- Publication number 20050267207
- Publication date Dec 1, 2005
- The Regents of the University of California
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Development of new selective estrogen receptor modulators
- Publication number 20050113453
- Publication date May 26, 2005
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thyronamine derivatives and analogs and methods of use thereof
- Publication number 20050096485
- Publication date May 5, 2005
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Non-steroidal ligands for the glucocorticoid receptor, compositions...
- Publication number 20050054700
- Publication date Mar 10, 2005
- The Regents of the University of California.
- Thomas S. Scanlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method for creating nuclear receptor activity modulating pharmaceut...
- Publication number 20040253648
- Publication date Dec 16, 2004
- The Regents of the University of California
- Robert J. Fletterick
- G01 - MEASURING TESTING
Information Patent Application
Method for creating specific, high affinity nuclear receptor pharma...
- Publication number 20040110154
- Publication date Jun 10, 2004
- The Regents of the University of California
- John D. Baxter
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
Eye treatments using synthetic thyroid hormone compositions
- Publication number 20030175849
- Publication date Sep 18, 2003
- The Regents of the University of California
- Daniel M. Schwartz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Thomas S. Scanlan

Person

Patents Grantslast 30 patents

Amide prodrugs of small molecule nuclear receptor modulators

Derivatives of sobetirome

Sobetirome in the treatment of myelination diseases

Amide compounds, pharmaceutical compositions thereof, and methods o...

Derivatives of sobetirome

Derivatives of sobetirome

Derivatives of sobetirome

Derivatives of sobetirome

Sobetirome in the treatment of myelination diseases

Derivatives of sobetirome

Development of new selective estrogen receptor modulators

Selective estrogen receptor modulator compositions and methods for...

Non-steroidal ligands for the glucocorticoid receptor, and composit...

Non-steroidal antiandrogens

Non-steroidal ligands for the glucocorticoid receptor, compositions...

Thyronamine derivatives and analogs and methods of use thereof

Thyronamine derivatives and analogs and methods of use thereof

Thyronamine derivatives and analogs and methods of use thereof

Method for creating specific, high affinity nuclear receptor pharma...

Development of new selective estrogen receptor modulators

Eye treatments using synthetic thyroid hormone compositions

Thyronamine derivatives and analogs and methods of use thereof

Non-steroidal ligands for the glucocorticoid receptor, compositions...

Eye treatments using synthetic thyroid hormone compositions

Nuclear receptor ligands and ligand binding domains

Nuclear receptor ligands and ligand binding domains

Thyroid hormone analogues and methods for their preparation

Eye treatments using synthetic thyroid hormone compositions

Peptide synthesis with sulfonyl protecting groups

Selective thyroid hormone analogs

Patents Applicationslast 30 patents

USE OF SOBETIROME AND PRODRUGS AND DERIVATIVES THEREOF FOR TREATING...

AMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS O...

AMIDE PRODRUGS OF SMALL MOLECULE NUCLEAR RECEPTOR MODULATORS

DERIVATIVES OF SOBETIROME

SOBETIROME IN THE TREATMENT OF MYELINATION DISEASES

DERIVATIVES OF SOBETIROME

DERIVATIVES OF SOBETIROME

DERIVATIVES OF SOBETIROME

SOBETIROME IN THE TREATMENT OF MYELINATION DISEASES

DERIVATIVES OF SOBETIROME

DERIVATIVES OF SOBETIROME

SOBETIROME IN THE TREATMENT OF MYELINATION DISEASES

FOOD OR BEVERAGE COMPOSITION FORTIFIED WITH THYRONAMINES AND/OR THY...

COMPOSITIONS INCLUDING 3,5-L-T2 AND METHODS OF USE THEREOF

NON-STEROIDAL LIGANDS FOR THE GLUCOCORTICOID RECEPTOR, COMPOSITIONS...

Development of New Selective Estrogen Receptor Modulators

FOOD OR BEVERAGE COMPOSITION FORTIFIED WITH THYRONAMINES AND/OR THY...

Non-Steroidal Ligands for the Glucocorticoid Receptor, Compositions...

SELECTIVE ESTROGEN RECEPTOR MODULATOR COMPOSITIONS AND METHODS FOR...

THYRONAMINE DERIVATIVES AND ANALOGS AND METHODS OF USE THEREOF

Development of new selective estrogen receptor modulators

Non-Steroidal Antiandrogens

Thyronamine derivatives and analogs and methods of use thereof

Thyronamine derivatives and analogs and methods of use thereof

Development of new selective estrogen receptor modulators

Thyronamine derivatives and analogs and methods of use thereof

Non-steroidal ligands for the glucocorticoid receptor, compositions...

Method for creating nuclear receptor activity modulating pharmaceut...

Method for creating specific, high affinity nuclear receptor pharma...

Eye treatments using synthetic thyroid hormone compositions